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SCIENTIFIC EDITORIAL
Aortic  prosthesis-patient  mismatch  in
patients  with  paradoxical  low  ﬂow  severe
aortic  stenosis:  A  dreadful  combination
Le  mismatch  patient-prothèse  aortique  chez  les  patients  avec
sténose  aortique  à  bas  débit  paradoxal  :  une  combinaison
tragique?
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The existence  of  low  ﬂow  in  patients  with  severe  aortic  stenosis  and  normal  left  ventricu-
lar  ejection  fraction  (LVEF),  commonly  called  ‘‘paradoxical  low  ﬂow’’  (PLF-AS),  was  ﬁrst
described  in  1997  by  Hachicha  et  al.  [1]  in  a  group  of  patients  with  severe  aortic  stenosis
on  the  basis  of  aortic  valve  area  (AVA)  <  1.0  cm2 and/or  indexed  AVA  <  0.6  cm2/m2.  These
patients  usually  have  lower  trans  aortic  mean  pressure  gradients  (<  40  mmHg)  despite  the
presence  of  preserved  LVEF  (≥  50%).  They  also  develop  a  restrictive  physiology,  resulting  in
low  cardiac  output  (stroke  volume  index  <  35  mL/m2).  PLF-AS  is,  in  fact,  present  typically
in  elderly  patients,  and  is  characterized  by  a  small,  calciﬁed  aortic  annulus  and  pronounced
concentric  remodeling,  resulting  in  a  small  ventricular  cavity  and  severe  diastolic  dysfunc-
tion  with  elevated  left  ventricular  (LV)  ﬁlling  pressures.  Several  studies  have  also  shown  a
depressed  LV  systolic  longitudinal  strain  despite  a  LVEF  >  50%  [2,3]  and  advanced  myocar-
dial  ﬁbrosis  (as  identiﬁed  by  cardiac  magnetic  resonance  imaging)  [4]. However,  PLF-AS
remains  a  controversial  entity  in  terms  of  its  prevalence,  outcome  and  management  [2,5].
Using  echocardiography,  PLF-AS  was  initially  found  in  approximately  30%  of  patients  withpréservée  ;
Mismatch
patient-prothèse
severe  aortic  stenosis  [1].  However,  Minners  et  al.  [6]  reported  that  echocardiography,
when  compared  with  cardiac  catheterization,  slightly  overestimates  the  prevalence  of
low  ﬂow  in  patients  with  aortic  stenosis.  Following  this  ﬁnding,  multiple  retrospective
or  prospective  studies  in  symptomatic  or  asymptomatic  patients  found  a  slightly  lower
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• ﬁfteen  per  cent  of  patients  with  preoperative  low  ﬂow 
revalence  when  taking  into  account  patients  with  aortic
tenosis  with  low  ﬂow,  and  low  gradient  and  preserved  LVEF,
anging  from  approximately  10%  to  20%  [2,5,6],  using  either
chocardiography  or  the  invasive  catheterization  method  for
ssessing  stroke  volume,  AVA  and  trans  aortic  mean  gradi-
nts.
The  main  issue  when  assessing  patients  with  PLF-AS  is
o  conﬁrm  the  severity  of  aortic  stenosis  and  recognize  the
otential  pitfalls  that  may  affect  its  evaluation,  namely:
potential  errors  in  measurement  (left  ventricular  outﬂow
tract  diameter,  left  ventricular  outﬂow  tract,  or  aortic
time-velocity  integral);
the  presence  of  other  signiﬁcant  valvular  disease;
the  presence  of  atrial  ﬁbrillation  during  echocardiogra-
phy.
The  other  possible  pitfall  of  PLF-AS  is  a  borderline  mod-
rate  to  severe  aortic  stenosis  due  to  the  inconsistencies  in
uidelines  between  gradients  and  AVA  cut-offs  [6]  (i.e.  1  cm2
orresponds  to  30  mmHg  gradients  instead  of  the  classical
0  mmHg  cutoff).
utcome and therapeutic issues in PLF-AS
ontroversy  exists  regarding  the  outcome  of  patients  with
LF-AS:  some  authors  found  it  may  increase  the  risk  of  short-
nd  long-term  overall  mortality  [3,5,7],  whereas  others
ound  similar  outcomes  to  those  in  patients  with  moder-
te  aortic  stenosis  [8].  Herrmann  et  al.  [4]  reported  a
ost-hoc  analysis  of  the  prospective  Placement  of  Aortic
ranscatheter  Valves  (PARTNER)  trial,  showing  that  patients
ith  aortic  stenosis  undergoing  transcatheter  aortic  valve
eplacement  (TAVR)  and  with  low  ﬂow  have  an  independent
igher  risk  of  mortality,  even  after  adjustment  for  LVEF  and
ean  pressure  gradient.
Overall,  several  studies  have  conﬁrmed  that  patients
ith  low  ﬂow  and  severe  aortic  stenosis  despite  a  preserved
VEF  are  at  advanced  stage  of  their  disease,  and  surgical  or
ercutaneous  aortic  valve  replacement  (AVR)  may  be  beneﬁ-
ial  when  compared  with  conservative  management  [9,10].
In  the  2012  European  guidelines,  this  form  of  severe  aor-
ic  stenosis  was  given  a  class  IIa  recommendation  for  surgery
n  symptomatic  patients.  Very  recently,  the  2014  American
ollege  of  Cardiology/American  Heart  Association  guidelines
ecommended  surgery  (class  IIa)  after  careful  evaluation  of
ortic  stenosis  severity  and  controlled  blood  pressure  [11].
However,  we  demonstrated  in  a  previous  study  [5]  that
espite  surgical  management,  patients  with  paradoxical
ow  ﬂow  (PLF)  exhibit  poor  survival  after  AVR  compared
o  those  with  classic  severe  aortic  stenosis  with  high  ﬂow
>  35  mL/m2).
ossible reasons for the poor outcome in
atients with PLF after AVR
fter  surgical  AVR,  some  patients  may  exhibit  moderate  or
evere  aortic  prosthesis-patient  mismatch  (PPM),  particu-
arly  in  those  who  receive  a  small  prosthesis.  A  moderate
PM  is  usually  deﬁned  as  an  in-vivo  effective  oriﬁce  area
•C.  Boulogne,  D.  Mohty
ndex  between  0.65  and  0.85  cm2/m2,  while  a  severe  PPM
ccurs  when  the  effective  oriﬁce  area  is  <  0.65  cm2/m2.
The  presence  of  moderate  or  severe  PPM  is  associ-
ted  with  higher  gradients  across  the  prosthesis  that  may
ead  to  worse  haemodynamics,  especially  in  young  patients
nd  in  those  with  signiﬁcant  LV  dysfunction  [12,13].  PPM
s  associated  with  less  regression  of  LV  hypertrophy  and
f  the  patient’s  symptoms  [14].  In  other  words,  patients
ith  PPM,  who  suffered  from  severe  aortic  stenosis  and
hronic  pressure  overload  for  many  years,  may  remain
ymptomatic  because  the  pressure  overload  superimposed
o  the  left  ventricle  is  not  removed  completely  after
VR.  Moreover,  in  patients  with  preoperative  classic  low
ow  (i.e.  associated  with  low  LVEF),  low  gradient  severe
ortic  stenosis,  the  presence  of  PPM  is  associated  with
igher  mortality  [15]. The  prevalence  and  prognostic  impact
f  PPM  in  patients  with  preoperative  PLF  are,  however,
nclear.
In  a  recent  study  from  our  group  [16],  we  sought  to
ssess  for  the  ﬁrst  time  the  prevalence  and  long-term  impact
f  moderate  to  severe  postoperative  PPM  in  patients  with
reoperative  PLF-AS.  The  hypothesis  was  that  PPM  is  not
are  after  AVR,  and  its  occurrence  in  patients  with  severe
ortic  stenosis  and  low  ﬂow  despite  preserved  LVEF  is  asso-
iated  with  decreased  survival.  The  study  involved  677
atients  who  had  surgical  aortic  valve  replacement  with
r  without  coronary  artery  bypass  graft  (CABG)  surgery
erformed  for  severe  aortic  stenosis  (aortic  valve  area
easured  by  the  invasive  Gorlin  method)  and  preserved
VEF.  The  patients  were  divided  into  four  groups  accord-
ng  to  the  presence  or  absence  of  PLF  and  the  presence
r  absence  of  at  least  moderate  PPM.  Almost  one-quarter
f  the  patients  died  over  a  mean  follow-up  of  more  than
 years.  The  30-day  postoperative  mortality  rate  (ranging
rom  3%  to  6%)  was  not  signiﬁcantly  different  among  the
our  groups  but  the  long-term  survival  rates  were  signiﬁcan-
ly  reduced  in  the  PLF-AS  group  versus  the  no  PLF-AS  group
P  =  0.004).  Moreover,  the  long-term  survival  rate  was  signi-
cantly  reduced  in  patients  with  PPM  versus  those  without
igniﬁcant  PPM  (P  =  0.01).  The  group  of  patients  with  both
LF  and  PPM  had  a  worse  overall  survival  rate  at  10  years
ompared  with  patients  free  of  PLF  and  PLM  (38%  vs  70%,
 =  0.002).  These  results  were  conﬁrmed  by  multivariable
nalysis  when  the  stroke  volume  index  and  effective  ori-
ce  area  were  entered  either  as  continuous  or  categorical
ariables,  with  a 2.6-fold  increase  in  long-term  mortal-
ty  versus  the  reference  group.  Thus,  the  main  messages
f  this  large  catheterization-based  study  in  patients  with
evere  aortic  stenosis  and  preserved  LVEF  undergoing  AVR  is
hat:
the  prevalence  of  low  ﬂow  was  present  in  one-quarter
of  this  cohort  study,  a  ﬁnding  similar  to  previous  studies
[2,5,6];
the  prevalence  of  moderate  to  severe  PPM  was  similar
to  that  reported  in  previous  studies  (almost  50%)  [17—19]
and  did  not  differ  between  patients  with  PLF-AS  and  those
with  normal  ﬂow;had  at  least  moderate  PPM  following  AVR;
PLF-AS  and  PPM  were  independently  associated  with
increased  long-term  mortality;
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• patients  with  both  preoperative  PLF-AS  and  postoperative
PPM  had  the  poorest  prognosis,  with  a  2.6-fold  increased
mortality  compared  to  those  with  neither  condition.
The impact of low stroke volume on
outcome
In  the  same  study  [16],  we  used  catheterization  data  to
deﬁne  low  ﬂow,  to  overcome  the  potential  errors  related  to
echocardiographic  measurements.  Our  study  conﬁrms  and
extends  previous  ﬁndings  [1,4—6]  and  demonstrates  that
reduced  stroke  volume  index  <  35  mL/m2 in  the  presence  of
preserved  LVEF  remains  signiﬁcantly  associated  with  total
mortality  after  AVR.
Stroke  volume  index  is  now  recognized  as  a  robust  vari-
able  testing  the  overall  efﬁciency  of  cardiac  pump  function
and  provides  important  incremental  prognostic  information
beyond  that  obtained  by  LVEF.  Conversely,  LVEF  underesti-
mates  the  extent  of  LV  systolic  dysfunction,  particularly  in
patients  with  signiﬁcant  concentric  LV  hypertrophy  such  as
those  with  aortic  stenosis,  because  it  remains  preserved  for
a  long  time  during  the  course  of  the  disease  despite  the
development  of  subclinical  and  intrinsic  myocardial  systolic
dysfunction  [2].  On  the  other  hand,  LV  outﬂow  stroke  volume
reﬂects  the  alteration  of  the  cardiac  pump  function,  which
may  result  from  impairment  of  LV  diastolic  and/or  systolic
function,  and  this  may  explain  why  this  simple  measure-
ment  has  a  strong  and  independent  correlation  with  poorer
outcome  and  survival  independent  of  LVEF  or  aortic  mean
gradient.  In  the  same  line,  it  is  likely  that  the  association
between  low  preoperative  mean  gradient  and  reduced  sur-
vival  after  AVR  [15]  is  related  in  large  part  to  the  presence
of  low  ﬂow  underlying  the  low  gradient.
Effect of PPM on outcome
Although  the  prevalence  of  PPM  and  its  effect  on  patient  out-
come  have  been  extensively  studied  over  the  past  10  years,
its  inﬂuence  on  outcome  remains  questioned.  Our  study  con-
ﬁrms  that  the  prevalence  of  PPM  is  approximately  50%  in
patients  with  severe  aortic  stenosis  after  AVR  [16]. This
ﬁnding  is  consistent  with  data  reported  in  previous  stud-
ies  [17,19].  Second,  our  ﬁndings  also  conﬁrm  the  effect  of
PPM  on  long-term  survival  also  reported  in  their  studies  and
conﬁrm  the  results  of  a  large  study  focusing  speciﬁcally  on
patients  operated  for  aortic  stenosis  [18].  Our  results  are
also  in  concert  with  the  results  of  two  large  meta-analysis,
which  included  studies  using  the  in-vivo  effective  oriﬁce
area  index  [20,21],  and  which  reported  that  PPM  is  inde-
pendently  associated  with  overall  survival.
The  negative  impact  of  PPM  on  long-term  survival  is
even  more  pronounced  in  patients  with  decreased  LVEF
[12,13,22].  In  our  study  [16],  although  only  patients  with
preserved  LVEF  were  included,  the  interaction  between  PPM
and  LV  stroke  volume  were  speciﬁcally  analysed.  We  found
that  moderate  to  severe  PPM  has  a  negative  effect  on  long-
term  survival  in  patients  with  PLF-AS  compared  to  those
with  normal  ﬂow  and  no  PPM.  This  new  ﬁnding  conﬁrms  that
patients  with  PLF-AS,  who  are  at  a  more  advanced  stage
of  disease  with  probable  latent  LV  dysfunction  despite  anlow  ﬂow  severe  aortic  stenosis  3
pparently  normal  LVEF,  may  not  tolerate  even  a small  LV
ostoperative  pressure  overload,  which  is  represented  by  a
oderate  mismatch.  Overall,  we  found  that  there  is  an  addi-
ive  negative  effect  of  both  PLF-AS  and  PPM  on  long-term
urvival  after  AVR.
Given  that  between  these  2  risk  factors,  only  the  avoid-
nce  of  PPM  is  potentially  possible  at  the  time  of  AVR,
herefore  strategies  that  reduce  the  incidence  and  severity
f  PPM  have  to  be  developed.  Clavel  et  al.  [7]  reported  that
PM  is  signiﬁcantly  less  frequent  after  TAVR  than  after  surgi-
al  AVR.  Furthermore,  a  post-hoc  analysis  of  the  PARTNER-IA
rial  revealed  that  patients  with  PLF-AS  had  better  1-year
urvival  when  randomized  to  TAVR  versus  surgical  AVR  [4].
owever,  on  the  basis  of  these  data,  we  cannot  draw  the
onclusion  that  TAVR  is  superior  to  surgical  AVR  in  patients
ith  PLF.  Therefore,  large  randomized  studies  are  needed  to
etermine  whether  TAVR  decreases  the  prevalence  of  PPM
nd  improves  survival  in  this  high-risk  group  of  patients.
onclusion
LF  and  PPM  coexist  in  a  substantial  proportion  of  patients
ith  severe  aortic  stenosis  undergoing  surgical  AVR  and  are
ndependently  associated  with  increased  mortality.  Stroke
olume  index  should  therefore  be  measured  systematically
nd  integrated  into  the  risk  stratiﬁcation  process  before  sur-
ical  AVR  and  efforts  should  be  undertaken  to  avoid  the
ccurrence  of  PPM,  particularly  in  these  high-risk  patients.
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